CLIC4 (chloride intracellular channel 4), a multifunctional protein that traffics between the cytoplasm and nucleus, interacts with Schnurri-2, a transcription factor in the bone morphogenetic protein (BMP) signalling pathway. Here we show that transforming growth factor β (TGF-β) promotes the expression of CLIC4 and Schnurri-2 as well as their association in the cytoplasm and their translocation to the nucleus. In the absence of CLIC4 or Schnurri-2, TGF-β signalling is abrogated. Direct nuclear targeting of CLIC4 enhances TGF-β signalling and removes the requirement for Schnurri-2. Nuclear CLIC4 associates with phospho (p)-Smad2 and p-Smad3, protecting them from dephosphorylation by nuclear phosphatases. An intact TGF-β signalling pathway is essential for CLIC4-mediated growth-arrest. These results newly identify Schnurri-2 and CLIC4 as modifiers of TGF-β signalling through their stabilization of p-Smad2 and 3 in the nucleus.
.
In addition to chloride channel activity in artificial and biological membranes, CLIC family members participate in cell-cycle control, cytoskeletal function, mitosis and differentiation 1 , but the pathway(s) through which they function are undefined. Analysis of the molecular structure of CLIC1 and CLIC4 has revealed dimorphic proteins that exist in both soluble and membrane-bound configurations, which are, at least in part, regulated by redox potential [2] [3] [4] . CLIC4 is essential for p53-and c-Mycmediated apoptosis and its promoter is a direct downstream target of these transcription factors 5, 6 . Cytoplasmic CLIC4 translocates to the nucleus under conditions of metabolic stress, growth arrest, apoptosis and DNA damage; this is mediated by a functional nuclear localization signal (NLS) on its carboxyl terminus. Nuclear residence is an essential component of CLIC4 pro-apoptotic and growth-arrest activity in keratinocytes 8 . In contrast, CLIC4 is excluded from the nucleus in epithelial cancer cells, but upregulated in tumour stromal cells that are associated with myofibroblast conversion 9 . CLIC4 has been linked to myofibroblast conversion in mammary fibroblasts treated with TGF-β (A002271; ref. 10 ). Thus, although CLIC4 participates in growth control and tissue remodelling, the signalling pathway through which it participates is not known.
We performed yeast two-hybrid assays using six CLIC4 sequences, spanning the entire protein, as baits. The CLIC4 bait comprising aminoacid residues 120-254 interacted with several potential binding proteins one of which was Schnurri-2 (which interacted with residues 814-1167), a zinc finger protein known to function in the TGF-β superfamily -decapentaplegic (Dpp)/BMP -signalling pathway [11] [12] [13] . We validated the interaction of CLIC4 and Schnurri-2 using co-immunoprecipitation assays in primary cultures of mouse keratinocytes expressing haemagglutinin (HA)-tagged CLIC4 or an empty vector. Schnurri-2-interacting proteins were co-immunoprecipitated using an anti-Schnurri-2 antibody. Immunoblotting of the SDS-PAGE-separated immunoprecipitates revealed both endogenous and exogenous CLIC4 ( Fig. 1a ; Supplementary  Information, Fig. S1a ), confirming the yeast two-hybrid results. CLIC4 and Schnurri-2 did not associate in vitro; full-length Schnurri-2 or its interacting domain failed to co-immunoprecipitate with recombinant full-length CLIC4 or the CLIC4 interacting domain (data not shown).
We transfected primary keratinocytes with adenoviral vectors expressing deletion constructs of C-terminal V5-His tagged CLIC4 ( Supplementary Information, Fig. S1b ). An anti-Schnurri-2 antibody co-precipitated both full-length CLIC4 (residues 1-253) and the region lacking the NLS (residues 1-197), but not the amino-terminal half (residues 1-120) or the region containing the transmembrane domain (residues 1-60; Supplementary Information, Fig. S1c ). We did not detect interaction with the regions containing residues 1-120 or 1-60, even at the highest exposures. Thus, Schnurri-2 interacts with a region of CLIC4 between residues 121 and 197, consistent with the bait region attracting Schnurri-2 in the yeast two-hybrid assay.
As CLIC4 causes cell-cycle arrest and Schnurri-2 participates in TGF-β superfamily signalling, we asked whether TGF-β could influence the interaction between CLIC4 and Schnurri-2. Whole-cell protein lysates from keratinocytes that had been treated with TGF-β1 for various times showed a persistent increase in CLIC4 and Schnurri-2 levels for up to 24 h after treatment (Fig. 1b) . This increase was transcriptional and sustained ( Supplementary Information, Fig. S2a ). Furthermore, skin biopsies from single-and double-transgenic mice overexpressing active TGF-β1 in the epidermis in response to doxycycline stimulation 14 showed elevated transcripts for both Schnurri-2 and CLIC4 within 4-5 days of treatment ( Supplementary Information, Fig. S2b ) . At this point, transcripts for the TGF-β response gene Smad7 are also increased, as reported previously. Thus, CLIC4 and Schnurri-2 respond to TGF-β stimulation similarly, both in vitro and in vivo. TGF-β also stimulates the interaction of CLIC4 and Schnurri-2. Co-immunoprecipitation experiments in keratinocytes showed an increase in the interaction of both endogenous and exogenous CLIC4 with Schnurri-2 within 30 min of TGF-β1 treatment ( Supplementary Information, Fig. S3 ). The interaction seemed to occur only in the cytoplasmic compartment of subcellular fractions, persisting for at least 6 h (Fig. 1c) . We did not detect any interaction of these proteins in the nucleus. The TGF-β-stimulated interaction of CLIC4 and Schnurri-2 is not Smad dependent, as it was not interrupted by short interfering RNA (siRNA)-mediated knockdown of Smad2, Smad3 or Smad4 ( Supplementary Information, Fig. S4 ).
Expression of exogenous CLIC4 in mouse keratinocytes modestly enhanced the activity of the TGF-β-dependent reporter plasmid p3TP-lux in response to a low dose (50 pg ml -1 ) of TGF-β1 (Fig. 2a) . CLIC4 increased the reporter activity in a TGF-β1-dose-dependent manner ( Supplementary Information, Fig. S5a ). This enhancement required the presence of Schnurri-2; expression of Schnurri-2 siRNA prevented CLIC4 from increasing TGF-β reporter activity ( Fig. 2a ; Supplementary  Information, Fig. S5a ). Growth inhibition is a major physiological response of keratinocytes to TGF-β. Exogenous CLIC4 alone inhibited keratinocyte DNA synthesis, and together with TGF-β1 inhibited DNA synthesis to a greater extent than TGF-β1 alone (Fig. 2b) ; this required Schnurri-2. Keratinocyte growth inhibition by CLIC4 and TGF-β also followed a TGF-β1 dose-dependent course ( Supplementary  Information, Fig. S5b 
Figure 1 TGF-β enhances the expression and association of CLIC4 and Schnurri-2. (a) An empty vector or HA-tagged CLIC4 was expressed in primary Balb/c keratinocytes using adenoviral constructs. Whole-cell lysates were immunoprecipitated (IP) using anti-CLIC4 or anti-Schnurri-2 antibodies and immunoblotted for CLIC4 and Schnurri-2. Antibodies (Ab) without cell lysates or cell lysates without antibodies were subjected to immunoprecipitation as controls. (b) Primary keratinocytes were treated with TGF-β1 (1 ng ml -1 ) for the indicated times. Whole-cell lysates were immunoblotted for CLIC4 and Schnurri-2. β-actin was used as a loading control. (c) An empty vector or HA-tagged CLIC4 was expressed in keratinocytes for 16 h and cells were then treated with TGF-β1
(1 ng ml -1 ) for the indicated times. Cytoplasmic and nuclear fractions were immunoprecipitated using an anti-Schnurri-2 antibody and immunoblotted (IB) for CLIC4 and Schnurri-2. Only exogenous CLIC4 was monitored because endogenous CLIC4 and IgG co-migrate in the presence of cell fractionation buffers. An anti-Schnurri-2 antibody was subjected to immunoprecipitation and immunoblotting without cell lysates as a control. Aliquots of the cytoplasmic and nuclear fractions were used directly as input for immunoblotting of CLIC4, lamin A-C and α-tubulin (α-tubulin and lamin A-C were used as controls for the cytoplasmic and nuclear fraction respectively). The lanes separated by a line are from the same gel. See Supplementary Information, Fig. S11 for uncropped scans. Keratinocytes were transfected with non-silencing (-) or Schnurri-2 (+) siRNA (si-Shnurri-2; inset in panel a) for 24 h, before being transduced with an empty vector or CLIC4 using adenoviral constructs. Cells were then treated with TGF-β1 (50 pg ml -1 ) for 14 h in a or 16 h in b. P3TP luciferase activity was normalized to pRLTK activity and data presented as fold change relative to that of a sample transduced with an empty vector and non-silencing siRNA (a; *P = 0.0125, **P = 0.0155, ***P = 0.0092).
3 H-thymidine incorporation is presented as a percentage of incorporation observed in an untreated sample transduced with an empty vector and non-silencing siRNA (b; *P = 0.0279, **P < 0.0001) . (c, d) HEK293 cells were transfected with pAct-Flag-hShn-2 (Schnurri-2) or transfection reagent alone (control) and treated with TGF-β1 (50 pg ml -1 ) for 16 h in c or 24 h in d. Luciferase data is presented as fold change relative to that of the control (c; *P = 0.0253, **P = 0.0291, ***P = 0.0357).
3 H-thymidine incorporation is presented as a percentage of incorporation observed in the control (d; *P = 0.015, **P < 0.0001, ***P = 0.0001). (e) Keratinocytes were transduced with a non-silencing (NS) or CLIC4 shRNA (sh-CLIC4; inset) adenovirus for 24 h before TGF-β1 treatment (50 pg ml -1 ) for 14 h. Luciferase data is presented as fold change relative to that of an untreated, non-silencing shRNAtransduced sample (*P = 0.0102). (f) Keratinocytes were transduced with CLIC4 shRNA as in e and treated with TGF-β1 for 16 h.
3 H-thymidine incorporation is presented as a percentage of incorporation observed in the untreated, non-silencing shRNA-transduced sample (*P = 0.0177, **P = 0.0005, ***P < 0.0001). (g, h) Keratinocytes were transduced with an empty vector or CLIC4 using adenoviral constructs (g) or CLIC4 knockdown vectors (h) for 16 h and then treated with TGF-β1 (1 ng ml -1 ) for 1 h. ImageJ software was used to quantify c-Myc and p21 bands, which are normalized to their respective β-actin controls and are represented as fold change relative to untreated empty vector-transduced samples. Data are mean ± s.d. in a-f, n = 4 in a-f. See Supplementary Information,  Fig. S11 for uncropped scans.
and it alters downstream signalling 12, 13 . We confirmed that Schnurri-2 also modifies TGF-β1 signalling in a mammalian system by introducing a Schnurri-2 expression plasmid, pAct-Flag-hShn-2, into a readily transfectable epithelial cell line, HEK293. Schnurri-2 alone caused CLIC4 to translocate to the nucleus and activated Smad2 (A002174) and suppressed c-Myc ( Supplementary Information, Fig. S6 ). Together with TGF-β1, Schnurri-2 increased TGF-β-dependent signal transduction, transcriptional activity and growth inhibition ( Fig. 2c, d ; Supplementary Information, Fig. S7a ). These results indicate that Schnurri-2 is involved in TGF-β signalling in addition to its known function in BMP signalling.
Next we examined the biological significance of CLIC4 in TGF-β responses. CLIC4 knockdown by short hairpin (sh) RNA-expression in keratinocytes reduced both TGF-β1-induced p3TP-lux activity and inhibition of thymidine incorporation by TGF-β1, further confirming participation of CLIC4 in TGF-β signalling (Fig. 2e, f) . Expressing exogenous CLIC4 in keratinocytes also enhanced both TGF-β1-dependent downregulation of c-Myc and upregulation of p21, even in the absence of TGF-β1 (Fig. 2g) . These changes are known to be involved in TGF-β-mediated growth inhibition 15, 16 . Furthermore, suppression of CLIC4 by shRNA enhanced c-Myc and reduced p21 expression in the absence of TGF-β1 and reduced c-Myc inhibition and p21 induction in the presence of TGF-β1 (Fig. 2h ).
TGF-β1 increased total CLIC4 and caused nuclear trafficking of CLIC4 in keratinocytes within 30 min of treatment (Fig. 3a) . Nuclear CLIC4 could be detected by confocal microscopy as early as 1 h after exposure to TGF-β1 (data not shown), and was sustained for at least 24 h (Fig. 3b) . In TGF-β1-exposed HEK293 cells, exogenous Schnurri-2 (pAct-Flag-hShn2) translocated to the nucleus in a time-course virtually identical to that observed for endogenous CLIC4 (Fig. 3c) . Confocal microscopy for Flag staining confirmed nuclear trafficking of Schnurri-2 ( Fig. 3d) . Together, these results support a mechanism whereby TGF-β1 enhances its activity through stimulating an interaction between CLIC4 and Schnurri-2 and promoting their nuclear translocation.
To confirm that nuclear translocation of CLIC4 by TGF-β1 has functional significance, we introduced a nuclear-targeted CLIC4-expressing adenovirus 7 into keratinocytes, and monitored TGF-β responses. Both wild-type and nuclear CLIC4 enhanced TGF-β1-dependent reporter activity, but nuclear CLIC4 was 10-fold more potent than wild-type CLIC4 (Fig. 3e) . TGF-β-dependent inhibition of DNA synthesis in keratinocytes was enhanced by both wild-type and nuclear-targeted CLIC4, but much more so by the latter. Furthermore, nuclear CLIC4 caused marked inhibition of DNA synthesis in the absence of exogenous TGF-β1 (Fig. 3f) . To examine whether growth inhibition by nuclear CLIC4 is TGF-β-dependent, we expressed exogenous wild-type and nuclear-targeted CLIC4 in primary keratinocytes from Smad3-knockout ) for 14 h. Luciferase assays were performed, p3TP activity was normalized to pRLTK activity and data presented as fold change relative to that of an untreated, empty vector-transduced sample (*P = 0.0074, **P < 0.0001, ***P = 0.0056,****P < 0.0001). (f) Keratinocytes were transduced as in e and treated with TGF-β1 (50 pg ml -1 ) for 16 h. H-thymidine incorporation is presented as a percentage of incorporation observed in the untreated empty vector-transduced sample (*P = 0.03, **P < 0.0001, ***P < 0.032, ****P < 0.0001). (g) Keratinocytes from Smad3 knockout (KO) mice or wild-type (WT) littermates were transduced as in e and treated with TGF-β1 (50 pg ml -1 ) for 16 h. mice and wild-type littermates, and treated cells with TGF-β1 for 16 h. Results indicate that the lack of Smad3 (A002175) increased thymidine incorporation (Fig. 3g) , consistent with a growth inhibitory function of the TGF-β pathway in this cell type. Wild-type CLIC4 and, especially, nuclear CLIC4 enhanced TGF-β-mediated growth inhibition in wildtype keratinocytes but were much less effective in Smad3-knockout keratinocytes. Whereas DNA synthesis in wild-type keratinocytes was inhibited 83-fold by overexpression of nuclear CLIC4, it was only inhibited 9-fold in Smad3-knockout cells, thus confirming that a completely intact TGF-β signalling pathway is essential for CLIC4-mediated keratinocyte growth inhibition.
To understand the mechanism by which Schnurri-2 facilitates CLIC4 enhancement of TGF-β signalling, we analysed the effect of Schnurri-2 siRNA expression on TGF-β1-dependent nuclear translocation of CLIC4. Knockdown of Schnurri-2 prevented CLIC4 from translocating to the nucleus after TGF-β1 treatment of keratinocytes (Fig. 4a, b) , indicating that Schnurri-2 is important for CLIC4 nuclear translocation in response to TGF-β1. We found that depletion of Schnurri-2 prevented wild-type CLIC4 from enhancing TGF-β1 transcriptional activation (Fig. 2a) , but did not prevent nuclear CLIC4 from enhancing TGF-β reporter activity (Fig. 4c) . This result was confirmed in immortalized mouse embryonic fibroblasts (MEFs) from Schnurri-2-knockout mice ( Supplementary  Information, Fig. S7b ). However, exogenous expression of Schnurri-2 restored the ability of wild-type CLIC4 to enhance TGF-β signalling in these cells. In contrast, nuclear-targeted CLIC4 enhanced reporter activity in the absence of Schnurri-2. Thus, the primary requirement for Schnurri-2 in this pathway is to facilitate CLIC4 nuclear translocation and not nuclear CLIC4 activity.
Nuclear targeting of CLIC4 enhanced nuclear p-Smad2 and 3 levels, even in the absence of exogenous TGF-β stimulation (Fig. 5a) . Expression of CLIC4 shRNA decreased nuclear p-Smad2 and 3 in both untreated and TGF-β1-treated (1 h) keratinocytes ( Supplementary  Information, Fig. S8a ). The targeting of a non-specific protein to the nucleus (green fluorescent protein, GFP) by an adenoviral vector 7 did not enhance levels of p-Smad2 or 3 (data not shown), indicating that nuclear CLIC4 has a specific effect. P-Smad2 and 3 levels were increased when endogenous or exogenous CLIC4 was targeted to the nucleus by TGF-β1 treatment; exogenous CLIC4 translocation sustained these levels for extended periods ( Supplementary Information,  Fig. S8b ). Smad4 levels were not altered by nuclear-targeted CLIC4 (Fig. 5a ). P-Smad2 and 3 are predominantly nuclear proteins, although phosphorylation occurs in the cytoplasm. Nuclear CLIC4 primarily enhanced nuclear p-Smad2 and 3, even in the absence of exogenous TGF-β1 (Fig. 5b) . However, nuclear CLIC4 did not enhance translocation of p-Smad2 or 3 from the cytoplasm to the nucleus in the absence or presence of exogenous TGF-β1, as cytoplasmic p-Smad2 or 3 were not reduced in its presence (Fig. 5b) . The increase in nuclear p-Smads was not a consequence of enhanced total Smad protein levels, as they remained unchanged (Fig. 5b) .When keratinocytes were treated with TGF-β type I receptor inhibitor SB431542, the overall levels of p-Smad2 decreased due to a blockade of basal Smad activation. Nevertheless, p-Smad2 levels were partially sustained by nuclear CLIC4 ( Supplementary Information, Fig. S9a ). This indicates that CLIC4 does not function through receptor-mediated phosphorylation and that spontaneous dephosphorylation of p-Smads is delayed by nuclear CLIC4.
After short TGF-β1 treatment, endogenous CLIC4 co-immunoprecipitated from keratinocyte nuclear fraction lysates with endogenous p-Smad2 and 3. However, the abundance of p-Smads (hence the level ) for 2 h or 6 h. Nuclear fractions were immunoblotted for CLIC4. Lamin A-C was used as a loading control. See Supplementary Information, Fig. S11 for the uncropped scan. (b) Keratinocytes were transfected with non-silencing (NS) or Schnurri-2 siRNA (si-Schnurri-2) 24 h before treatment with TGF-β1 for 6 h. Cells were immunostained with anti-CLIC4 primary and rhodaminelabelled secondary antibodies (red) and visualized by confocal microscopy with or without DAPI (blue) to visualize nuclei. Scale bar, 20 μm. (c) Keratinocytes were transfected with a p3TP-lux or pRLTK (control) plasmid and non-silencing (-) or Schnurri-2 (+) siRNA before transduction with adenoviral constructs expressing empty control vector (vector), wild-type CLIC4 or nuclear-targeted (nuc) CLIC4 and then treatment with TGF-β1 (50 pg ml -1 ) for 14 h. Luciferase assays were performed and data presented as fold change relative to that of a non-silencing siRNA-transfected sample. Data are mean ± s.d. from quadruplicates (n = 4) of a representative experiment (*P = 0.023, **P = 0.0068, ***P = 0.0005).
of immunoprecipitated p-Smads) diminished over 3 h, consistent with the reported degradation of nuclear p-Smads after TGF-β1 treatment 17 .
These results indicate that CLIC4 directly interacts with p-Smad2 and 3 in keratinocytes. Co-immunoprecipitation analysis demonstrates that CLIC4 also interacts with Smad4 ( Supplementary Information,  Fig. S9b ). ) were immunoblotted for the indicated proteins. Lamin A-C was used as a loading control. (b) Cytoplasmic and nuclear lysates from primary keratinocytes transduced and treated as in panel a were immunoblotted for p-Smad2, p-Smad3 and total Smad2 and 3. Lamin A-C and α-tubulin were used as loading and subcellular fraction purity controls. The separated sections of the p-Smad3 blot are from the same gel, but reflect adjusted exposure times for optimal visualization. (c) Nuclear lysates of keratinocytes untreated or treated with TGF-β1 for indicated times were immunoprecipitated (IP) with an anti-CLIC4 antibody and immunoblotted (IB) for p-Smad2, p-Smad3 and CLIC4. An anti-CLIC4 antibody (Ab) without cell lysates and cell lysates without antibodies were subjected to immunoprecipitation as controls. An aliquot of lysates used for immunoprecipitation was used as input. (d) Primary keratinocytes were transduced and treated as in panel a. Nuclear lysates were dephosphorylated using indicated amounts of λ-PPase, and immunoblotted for p-Smad2 and 3. Lamin A-C was used as a loading control. The exposure time for TGF-β1-treated samples was adjusted to compensate for the higher p-Smad2 and 3 levels. ImageJ software was used to quantify p-Smad2 and 3 bands, which are normalized to their respective lamin A-C controls. (e) Nuclear lysates of keratinocytes transduced and treated as in panel a were immunoprecipitated with an anti-PPM1a antibody and immunoblotted for p-Smad2, p-Smad3 and PPM1a. An anti-PPM1a antibody without cell lysates and lysates without an antibody were subjected to immunoprecipitation and used as controls. (f) Primary Balb/c keratinocytes were transfected with non-silencing (-) or PPM1a (+) siRNA 48 h before transduction with an empty control vector (vector), wild-type CLIC4 or nuclear targeted CLIC4 for 16 h, followed by treatment with TGF-β1 (1 ng ml -1 ) for 1 h. Lysates were separated by SDS-PAGE and immunoblotted for p-Smad2, p-Smad3 and PPM1a. Lamin A-C was used as a loading control. See Supplementary Information, Fig. S11 for uncropped scans.
Among the complexities of TGF-β signalling, a dynamic interplay of Smad phosphorylation and dephosphorylation regulates nuclear responses. Ligand stimulation results in Smad phosphorylation and Smad-complex accumulation at the nucleus where Smad is dephosphorylated and exported, thereby terminating the signal 18, 19 . To understand whether physical association of CLIC4 with p-Smad2 and 3 could protect them from dephosphorylation, we exposed nuclear lysates of keratinocytes transduced with either an empty vector (control), wild-type or nuclear-targeted CLIC4 adenovirus to lambda protein phosphatase (λ-PPase, a serine threonine phosphatase). P-Smad2 and 3 in lysates containing nuclear CLIC4 were the most resistant to dephosphorylation, regardless of TGF-β treatment (Fig. 5d ). Relative to their respective untreated samples, λ-PPase (2 U) dephosphorylated p-Smad2 by ~75% and ~50%, in empty vector-and wild-type CLIC4-expressing samples, respectively, but only by 10% in nuclear-targeted CLIC4-expressing samples. Similarly, p-Smad3 was dephosphorylated by ~80-95% in empty vector-, ~70-80% in wild-type CLIC4-and by only 50% in nuclear CLIC4-expressing samples. Thus, in this assay nuclear CLIC4 and, to a lesser extent, wild-type CLIC4 protected p-Smad2 and 3 from phosphatases. With short TGF-β exposure (1 h), only small amounts of wildtype CLIC4 are expected in the nucleus.
Protein phosphatase 1a (PPM1a) has been identified as a Smadbinding protein and a Smad phosphatase 18 . When nuclear CLIC4 was overexpressed in TGF-β-treated keratinocytes, co-immunoprecipitation of p-Smad2 and 3 with PPM1a was inhibited (Fig. 5e) . Notably, wild-type CLIC4 also inhibited the interaction of p-Smad2 and 3 with PPM1a, consistent with CLIC4 translocation to the nucleus after TGF-β treatment. siRNA-mediated knockdown of PPM1a increased levels of p-Smad2 and 3 in keratinocytes transduced with an empty vector or wild-type CLIC4, but did not enhance levels in samples with nucleartargeted CLIC4 (Fig. 5f ). This indicates that at least part of the nuclear CLIC4 effect on p-Smad2 and 3 stabilization is due to its inhibition of PPM1a interaction with p-Smads. That the levels of p-Smad2 and 3 in empty vector-and wild-type CLIC4-expressing cells did not rise to the levels of those in nuclear-targeted CLIC4-expressing cells after PPM1a knockdown might indicate that other, yet to be described, Smad phosphatases are also inhibited by nuclear CLIC4 (or perhaps the knockdown of PPM1a was incomplete).
These results indicate a new mechanism for enhancement of TGF-β signalling: TGF-β stimulates the association of Schnurri-2 and CLIC4 in the cytoplasm, leading to Schnurri-2-dependent nuclear translocation of the complex where it dissociates. Nuclear CLIC4 stabilizes nuclear p-Smad2 and 3 levels by associating with these proteins and protecting them from dephosphorylation by PPM1a, and possibly other Smad phosphatases; thus enhancing and sustaining TGF-β nuclear signalling ( Supplementary Information, Fig. S10 ). The protection of nuclear p-Smads by CLIC4 increases both early (c-Myc downregulation and p21 upregulation) and later (growth inhibition) functions of TGF-β signalling, while also prolonging responses. A positive feedback loop may also be established, as a consequence of TGF-β signalling is to increase both Schnurri-2 and CLIC4 expression.
Previous data have indicated that the CLIC4 NLS is required for nuclear translocation in response to cell stress 7 , suggesting that, apart from TGF-β stimulation, there are other mechanisms regulating CLIC4 nuclear translocation independent of Schnurri-2. Nevertheless, TGF-β signalling could be downstream from CLIC4 nuclear translocation (in response to stress and cell-cycle arrest) as well as from the participation of CLIC4 in myofibroblast conversion. CLIC4 loss in tumours could contribute to tumour resistance to TGF-β signalling. Schnurri-2 and CLIC4 now join a panoply of Smad signalling regulators in the nucleus, reflecting the need for precise TGF-β signalling control. In addition to p-Smad dephosphorylation by PPM1a, there is the Arkadia-mediated degradation of the co-repressor SnoN (Ski-related novel protein N) 20 , the direct action of Arkadia on both activation and degradation of p-Smads 17 and retention of Smad proteins in the nucleus by TAZ (transcriptional co-activator with PDZ binding motif) 21 . Together, the combination of Schnurri-2 and CLIC4 present a unique duo of new players in a critical pathway that controls diverse aspects of cell behaviour. Schnurri-2 and CLIC4 may serve as targets for modifying TGF-β signalling under conditions where this pathway is involved in pathological changes.
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METHODS
Cell culture, expression vectors and transfection. Primary keratinocytes from newborn Balb/c mice and Smad3 knockout mice (provided by L. Wakefield, National Cancer Institute, MD) were prepared and cultured according to established methods 22 . Readily transfectable epithelial HEK293 cells were cultured in Dulbecco's Modified Eagles Medium (DMEM) supplemented with newborn calf serum (10%). Adenoviral Smad4 was provided by A. Glick (Pennsylvania State University, PA). A Schnurri-2 expression plasmid, pAct-Flag-hShn-2, was provided by S. Ishii (RIKEN Tsukuba Institute, Japan). Primary MEFs from Schnurri-2 knockout mice (provided by S. Ishii) 23 were immortalized by pRSV-T and cultured in DMEM with newborn calf serum (10%). Transfections were performed using Lipofectamine 2000 (Invitrogen). Generation of HA-CLIC4, nuclear targeted CLIC4, V5-His tagged full length CLIC4 and deletion constructs lacking the NLS and the C-terminal half were as described previously 7 . The deletion mutant construct expressing CLIC4 amino-terminal amino-acid residues 1-60 was generated similarly. Cells were transduced with CLIC4 expression vectors for 16 h before TGF-β1 treatment.
Construction of adenovirus expressing CLIC4 shRNA. CLIC4 sequence 5ʹ-gggctgaaggaggaggacaaagag-3ʹ was sequentially cloned into pENTR/H1/TO and pLenti4/Block iT/Dest vectors (Invitrogen) to produce pLenti6/ Block iT-GW/ U6 as the final vector. The inducible portion of this vector was subcloned into Ad5 RNAi adenovirus (ABM) and amplified by the Adenovirus Core Facility (Frederick National Cancer Institute, MD). CLIC4 shRNA is constitutively active without requiring the TetR transactivator expression system and is homologous to both human and mouse CLIC4, allowing it to be used for both species. For nonspecific shRNA, 5ʹ-gttctccgagagtgtcacgt-3ʹ was used (Cellogenetics).
Schnurri-2, Smad2, Smad3, Smad4 and PPM1a siRNA. Schnurri-2 siRNA (5ʹ-uuaggauauaaagcccuuc-3ʹ), Smad2 siRNA (5ʹ-uaguaugcgauugaacacc-3ʹ), Smad3 siRNA (5'-cgaguguaaauuauuucaa-3'), Smad4 siRNA (5'-agaugaauuggauucuuua-3ʹ), PPM1a siRNA (5ʹ-uuggaauucuuccuaaucg-3ʹ) and non-silencing siRNA (5ʹ-uucuccgaacgugucacgudtdt-3ʹ) were obtained from Qiagen and transfected using HiPerfect (20 nM; Qiagen). At 24 h post-transfection with Schnurri-2 siRNA and 48 h post transfection with Smad2 and PPM1a siRNAs, cells were treated with TGF-β1 or infected with a control, CLIC4 or nuclear CLIC4 adenovirus.
Yeast two-hybrid assay. The CLIC4 yeast two-hybrid screen was conducted by Myriad Genetics, based on established methodology 24 . CLIC4 cDNA fragments were cloned into pGBT.superB, a GAL4 DNA-binding domain (residues 1-441) plasmid, and used as bait to screen a mouse embryo cDNA library cloned into a pGAD.PN2 plasmid containing a GAL4 activation domain (residues 2301-2643). Bait-transformed PYN200 cells were mated with prey-transformed BK100 cells and plated on selective media. Interactions were confirmed by transforming naive yeast cells with purified bait and prey constructs and assaying for β-galactosidase using a chemiluminescent assay. Although multiple bait constructs spanning the entire CLIC4 open reading frame were screened separately, only residues 120-254 successfully recruited prey.
Antibody generation, subcellular fractionation, co-immunoprecipitation and immunoblotting. A monospecific polyclonal antibody was generated against the N-terminal peptide of CLIC4 as described previously 25 . The polyclonal serum was purified through a protein A column (Pharmacia) and dialyzed in borate buffer. The following antibodies were used: anti-c-Myc and anti-p-Smad2 (1:1000 dilution; Cell Signalling Technologies), anti-p21 (1:1000 dilution; BD Biosciences), anti-Smad4 (1:1000 dilution), anti-Schnurri-2 (1:500 dilution) and anti-Lamin A-C (1:500 dilution; Santa Cruz Biotechnologies), anti-PPM1a (1: 1000 dilution; Abcam), anti-α-tubulin (1:1000 dilution; Bethyl Laboratories) and anti-p-Smad3 (1:5000 dilution; a gift from E. Leof, Mayo Clinic, MN). Keratinocytes or HEK293 cells were washed and scraped into a lysis buffer (Cell Signalling Technologies). Nuclear and cytoplasmic extracts were produced using NE-PER (Thermo Fischer Scientific). Protein (25 μg) was subjected to immunoblotting and then visualized using enhanced chemiluminescence (Thermo Fischer Scientific).
For immunoprecipitation, cells were washed with cold phosphate-buffered saline (PBS) and lysed in M-PER (Thermo Fischer Scientific) containing protease and phosphatase inhibitors. Lysates were precleared with protein A-G PLUS agarose beads and then incubated overnight with the antibody of interest and protein A/G PLUS agarose beads at 4 °C. Beads were washed and boiled before electrophoresis of the eluate. Co-immunoprecipitation from nuclear fractions was performed using the Nuclear Complex Co-IP kit (Active Motif).
Luciferase assay. TGF-β-responsive p3TP luciferase reporter (p3TP-lux) was used in a luciferase assay. Keratinocytes plated in 12-well culture plates were transfected with p3TP-lux (2.0 μg per well) and pRLTK (0.2 μg per well). Cells were transduced in quadruplicate with a wild-type CLIC4-, nuclear targeted CLIC4-, empty vector-, CLIC4 shRNA-or non-silencing shRNA-expressing adenovirus. At 3 h after infection they were treated with TGF-β1 (50 pg per well) for 14 h. Luciferase activity was determined in cell extracts using the Dual Luciferase Reporter assay system (Promega) and normalized to Renilla luciferase activity. To determine Schnurri-2-mediated changes in p3TP-lux-luciferase activity, the procedure described above was followed, except that HEK293 cells were transfected with the Schnurri-2 expression plasmid for 24 h before exposure to TGF-β1. H-thymidine (1 μCi per well) was added for 3 h before the end of the TGF-β1 treatment. Cells were fixed using methanol and acetic acid (3:1 ratio), solubilized in NaOH (5 normal) and incorporated counts were measured using a scintillation counter.
Confocal microscopy. Cells were fixed in 2% paraformaldehyde/PBS (phosphate buffered saline) for 30 min, washed with PBS, permeabilized with cold methanol for 6 min and dried briefly. Samples were then re-hydrated and washed with PBS, treated with glycine (100 mM) for 30 min, equilibrated with Triton X-100 (0.2%) for 10 min, washed with PBS and blocked in 0.5% bovine serum albumin (BSA)/ PBS for 1 h. This was followed by overnight incubation with a primary antibody (anti-CLIC4 or anti-Schnurri-2) at 4 °C, washing with PBS and incubation in the dark with a fluorescence-labelled secondary antibody for 1 h. The plates were washed again, Vectashield mounting medium with DAPI (Vector Laboratories) was added for nuclear staining and cells were analysed by confocal microscopy (Zeiss-NLO microscope).
Dephosphorylation of nuclear extracts using lambda protein phosphatase. Nuclear extracts of keratinocytes transduced with control, wild-type or nuclear targeted CLIC4 adenovirus with or without treatment with TGF-β for 1 h were dephosphorylated using lambda protein phosphatase (New England Biolabs) at 30 °C for 30 min. Reactions were stopped by adding 2× SDS-PAGE sample buffer and heating for 5 min at 100 °C.
Reverse transcription (RT)-PCR. TGF-β1-treated total RNA from keratinocytes was isolated using Tri zol (Invitrogen), subjected to DNAse I (Ambion) treatment and reverse transcribed using SuperScript II Reverse Transcriptase (Invitrogen). PCR amplification of CLIC4 and Schnurri-2 was carried out using Platinum Supermix (Invitrogen). Sequences for Schnurri-2 primers were 5ʹ-GGAAAGAGGGAAAGGAGAGATTCACGGAGAT-3ʹ and 5ʹ-ATCTGAGTGTCATCACAAGAGTCACTGGGT-3ʹ. CLIC4 primers were from Superarray (PPH08576A) and GAPDH primers were from Gene Link (40-1005-10). For in vivo analysis, cDNA (provided by A. Glick) was reverse transcribed from RNA isolated from the skin of single-(control) or double-transgenic mice engineered to express active TGF-β1 from skin keratinocytes after induction by doxycycline 14 . For real-time PCR analysis, predesigned Quantitect primers (Qiagen), BioRad iQ iCycler and Gene Expression Macro were used. Figure S2 TGF-β enhances transcription of CLIC4 and Schnurri-2 in the skin in vitro and in vivo. (a) Primary Balb/c keratinocytes were treated with TGF-β1 (1ng/ml) for indicated times. Total cellular RNA was isolated and subjected to reverse transcription and PCR amplified to detect CLIC4 and Schnurri-2. GAPDH was used as PCR control. (b)Real-time PCR analysis of CLIC4, Schnurri-2 and Smad7 mRNA levels in skin of tetOTGFβ1 (ST) and K5/rTA -tetOTGFβ1 (DT) mice fed with doxycycline (Dox) for 4-5 days. RNA was isolated from skin biopsies and cDNA synthesized using High-capacity cDNA kit from Applied Biosystems. Bars represent mean value ± SEM. ST and DT groups contain 5 and 6 animals respectively.
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TGF-! enhances transcription of CLIC4 and Schnurri-2 in the skin in vitro and in vivo. (a) Primary Balb/c keratinocytes were treated with TGF-!1 (1ng/ml) for indicated times. Total cellular RNA was isolated and subjected to reverse transcription and PCR amplified to detect CLIC4 and Schnurri-2. GAPDH was used as PCR control. (b)Real-time PCR analysis of CLIC4, Schnurri-2 and Smad7 mRNA levels in skin of tetOTGF!1 (ST) and K5/rTA -tetOTGF!1 (DT) mice fed with doxycycline (Dox) for 4-5 days. RNA was isolated from skin biopsies and cDNA synthesized using High-capacity cDNA kit from Applied Biosystems. Bars represent mean value ± SEM. ST and DT groups contain 5 and 6 animals respectively. TGF-β dependent interaction of CLIC4 and Schnurri-2 is Smad independent. Primary keratinocytes were transfected with Smad2-3-4 siRNA 48h prior to transduction with empty or CLIC4 adenoviral vectors followed by treatment with TGF-β(1ng/ml) for 1h. Lysates were immunoprecipitated using anti-Schnurri-2 antibody and immunoblotted for CLIC4 and Schnurri-2. Anti-Schnurri-2 antibody without cell lysate and lysate alone without antibody were subjected to immunoprecipitation and used as control. An aliquot of the lysates was used to detect input Smad2, 3 and 4.
TGF-! dependent interaction of CLIC4 and Schnurri-2 is Smad independent. Primary keratinocytes we transfected with Smad2-3-4 siRNA 48h prior to transduction with empty or CLIC4 adenoviral vectors followed treatment with TGF-!(1ng/ml) for 1h. Lysates were immunoprecipitated using anti-Schnurri-2 antibody and im for CLIC4 and Schnurri-2. Anti-Schnurri-2 antibody without cell lysate and lysate alone without antibody were immunoprecipitation and used as control. An aliquot of the lysates was used to detect input Smad2, 3 and 4. (b) Immortalized MEFs from Schnurri-2 knockout mice were transfected with p3TP-lux and pRLTK and pAct-FLAG-hShn2 or lipofectamine alone. Cells were transduced with empty vector, wild type CLIC4 or nuclear targeted CLIC4 adenoviruses +/-TGF-β1 ( 1 ng/ml) treatment for 14h. Reporter luciferase activity was determined in cell extracts using Dual luciferase reporter assay system (Promega) and normalized to renilla luciferase activity. Data are presented as fold change of untreated Vector sample. Each data point is an average of quadruplicates (n=4) from a representative experiment. Figure S9 CLIC4 enhances phospho-Smad2 independent of receptor activity and interacts with Smad4 (a) Primary keratinocytes were transduced with empty, wild-type or nuclear CLIC4 adenoviruses for 16h and one group was treated with SB431542 for the entire length of transduction. Nuclear lysates were immunoblotted for phospho-Smad2. Lamin A/C was used as loading control. The percent reduction in p-Smad2 levels in the SB431542 treated samples relative to their respective untreated controls is indicated. (b) Adenoviral Smad4 was expressed in primary keratinocytes followed by treatment with TGF-β1(1 ng/ml) for 30 min. Lysates were immunoprecipitated using CLIC4 antibody and immunoblotted for Smad4 and CLIC4. An aliquot of the lysates was used directly as input for immunoblotting for Smad4. 
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CLIC4 enhances phospho-Smad2 independent of receptor activity and interacts with Smad4 (a) Primary keratinocytes were transduced with empty, wild-type or nuclear CLIC4 adenoviruses for 16h and one group was treated with SB431542 for the entire length of transduction. Nuclear lysates were immunoblotted for phospho-Smad2. Lamin A/C was used as loading control. The percent reduction in p-Smad2 levels in the SB431542 treated samples relative to their respective untreated controls is indicated. (b) Adenoviral Smad4 was expressed in primary keratinocytes followed by treatment with TGF-!1(1 ng/ml) for 30 min. Lysates were immunoprecipitated using CLIC4 antibody and immunoblotted for Smad4 and CLIC4. An aliquot of the lysates was used directly as input for immunoblotting for Smad4. 
